BAX vs IONQ
BAX: Baxter is a global medtech leader providing essential infusion, surgical, and connected care technologies that support acute and chronic healthcare delivery. IONQ: IonQ is a leader in trapped-ion quantum computing, providing cloud-based access to high-performance quantum processors for research and commercial use.
Side-by-side fundamentals
| Metric | BAX | IONQ | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $23.00 | $30.04 | |
| Market cap | $11.9B | $11.4B | |
| Net margin FY2025, SEC XBRL | -8.5% | -392.6% | BAX higher |
| Gross margin FY2025, SEC XBRL | +30.1% | n/a | |
| Operating margin FY2025, SEC XBRL | -2.7% | -487.4% | BAX higher |
| ROE FY2025, SEC XBRL | -15.7% | -13.4% | IONQ higher |
| ROA FY2025, SEC XBRL | -4.8% | -7.8% | BAX higher |
| Debt / equity | 1.54 | 0.00 | IONQ lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +5.7% | +201.8% | IONQ higher |
| Revenue CAGR (3y) SEC XBRL | +3.8% | +126.9% | IONQ higher |
| Dividend yield as of 2026-09-03 | 0.17% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | 0 | BAX higher |
| Beta as of 2026-09-03 | 0.92 | 2.91 | |
| 1-year return as of 2026-10-30 close | +20.0% | -50.1% | BAX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.